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The International Association for the Study of Lung Cancer (IASLC) is a global network of scientists, health care professionals, and advocates working together to conquer tho-
racic malignancies through research, education, and advocacy. As the mouthpiece of this 
organization, the Journal of Thoracic Oncology aims to further the strategic goals of the 
IASLC by being the major forum in which all scholarly activities in these subject areas are 
disseminated and discussed. In aiming to serve our readers and IASLC members better, we 
constantly listen to you and strive to improve the journal, based on our own research and 
your suggestions.
Along these lines, open access for all manuscripts upon request by the authors was 
introduced last year. We believe that our turn-around time is one of the best in the field. 
In 2013, our average time from manuscript submission to first decision was 14 days, and 
the time from submission to final decision was 28 days. Our average time from manuscript 
acceptance to print publication was 3.5 months, with online publication ahead of print 
occurring about 1.5 months earlier.
However, with the rapid dissemination of information in all aspects of life in our 
current technology and information age, you, our authors have been asking for even faster 
publication times. After careful deliberation by the editorial board, this journal is pleased to 
provide Publish Upon Acceptance for all accepted manuscripts, starting with articles slated 
for Volume 10, Issue 1, January 2015. Upon acceptance, the most recent version of the 
manuscript will be promptly posted in the Publish Ahead of Print section of the journal web 
site. When the article is subsequently copyedited and published in an issue, this raw version 
will be removed. For this rapid turn-around to work efficiently, authors are urged to submit 
all copyright forms promptly with their manuscripts on submission or at the latest, at the 
revision stage. In addition, authors are urged to pay careful attention to detail in manuscript 
preparation, and ensure accuracy of tables, while providing high quality figures, on submis-
sion. As this new mechanism is introduced, it is anticipated that there will be a period of 
time when publish upon acceptance manuscripts will appear online before articles already 
accepted and in press. However, this lag will not last more than a few months.
Finally, we are pleased to encourage all our authors to obtain an Open Researcher and 
Contributor ID (ORCID). This unique identifier allows us to avoid confusion with author 
identities, prevent duplicate publication, and assist in identifying suitable reviewers. Please 
visit ORCID (https://orcid.org/register) to register. You can then go to the “Update My 
Information” page on the JTO web site, and enter and verify your ORCID. Your accepted 
submissions will then be automatically added to your ORCID publication record.
Thank you for your continued support of the Journal of Thoracic Oncology.
Alex A. Adjei, MD, PhD
Editor-in-Chief
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